Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.367NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.385NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.385NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.385NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.244NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.244NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.244NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JD.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.17.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.17.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.7.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.7.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.7.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.10.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.10.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.10.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KG.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KG.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HA.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HA.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.351 (Beta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.351 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351 (Beta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used